Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO
· Real-Time Price · USD
1.98
-0.06 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
2.02
2.28%
After-hours: Aug 15, 2025, 07:41 PM EDT
Aptevo Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 9.41M | 2.14M | 8.71M | 7.75M | 8.07M | 10.25M | 16.9M | 19.11M | 21.01M | 25.33M | 22.64M | 22.15M | 29.43M | 34.99M | 45.04M | 52.12M | 60.39M | 57.52M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.23M | -6.48M | -6.76M | -7.08M | n/a | 68K | 68K | 746K | 746K | 746K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M | n/a | n/a | 3.11M | 3.66M | 3.1M | 3.11M | 2.42M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.57M | n/a | n/a | 2.69M | 3.08M | 3.65M | 2.19M | 2.82M |
Other Current Assets | 82K | 120K | 256K | 624K | 715K | 691K | 689K | 649K | 764K | 1.58M | 744K | 1.08M | 1.31M | 2.14M | 2.04M | 1.27M | 1.32M | 1.34M |
Total Current Assets | 11.08M | 3.61M | 10.66M | 10.01M | 9.58M | 12.07M | 19.07M | 21.13M | 22.68M | 28.48M | 27.45M | 24.62M | 31.4M | 41.67M | 52.57M | 58.87M | 65.77M | 62.85M |
Property-Plant & Equipment | 4.54M | 4.74M | 4.93M | 5.13M | 5.34M | 5.55M | 5.78M | 6M | 6.23M | 6.48M | 6.76M | 7.08M | 7.4M | 3.44M | 3.96M | 4.39M | 4.96M | 5.16M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 4.54M | 4.74M | 4.93M | 5.13M | 5.34M | 5.55M | 5.78M | 6M | 6.23M | 6.48M | 6.76M | 7.08M | 7.4M | 3.51M | 4.03M | 5.13M | 5.71M | 5.9M |
Total Assets | 15.62M | 8.34M | 15.59M | 15.15M | 14.92M | 17.63M | 24.84M | 27.13M | 28.91M | 34.97M | 34.22M | 31.7M | 38.8M | 45.18M | 56.6M | 64M | 71.47M | 68.75M |
Account Payables | 2.9M | 3.79M | 3.05M | 3.53M | 3.74M | 3.72M | 3.98M | 4M | 4.87M | 4.13M | 3.5M | 3.24M | 3.27M | 3.91M | 3.46M | 3.69M | 5.2M | 5.35M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.5M | n/a | 1.7M | 1.04M | -3.46M | -3.69M | -5.2M | 1.1M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2M | 2M | 2M | 2M | 11.67M | 11.17M | 10.67M | 10.17M |
Other Current Liabilities | 1.99M | 1.6M | 3.15M | 1.43M | 791K | 968K | 1.14M | 1.31M | 746K | 1.04M | 1.1M | 1.17M | 30K | 16.91M | 17.55M | 15.96M | 13.8M | 12.73M |
Total Current Liabilities | 4.89M | 5.39M | 6.21M | 5.88M | 5.42M | 6.3M | 7.22M | 6.84M | 6.91M | 5.8M | 8.71M | 7.79M | 7M | 23.86M | 34.76M | 32.38M | 30.86M | 29.34M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.46M | 1.91M | 2.36M | 2.8M | 3.71M | 4.01M | 4.32M | 4.61M |
Other Long-Term Liabilities | n/a | n/a | n/a | 14K | 14K | 14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23.34M | 15.58M | 18.71M | 20.54M | 22.17M |
Total Long-Term Liabilities | 4.21M | 4.42M | 4.63M | 4.84M | 5.04M | 5.23M | 5.4M | 5.58M | 5.75M | 5.92M | 7.54M | 8.15M | 8.75M | 27.21M | 20.63M | 24.33M | 26.73M | 28.91M |
Total Liabilities | 9.1M | 9.81M | 10.84M | 10.73M | 10.46M | 11.53M | 12.62M | 12.41M | 12.66M | 11.71M | 16.24M | 15.93M | 15.75M | 51.07M | 55.38M | 56.71M | 57.59M | 58.25M |
Total Debt | 4.21M | 4.42M | 4.63M | 4.83M | 5.03M | 5.21M | 5.4M | 5.58M | 5.75M | 5.92M | 9.54M | 10.15M | 10.75M | 5.87M | 16.71M | 16.79M | 16.86M | 16.9M |
Common Stock | 99K | 84K | 84K | 82K | 69K | 66K | 61K | 56K | 49K | 49K | 48K | 47K | 47K | 47K | 47K | 47K | 47K | 46K |
Retained Earnings | -260.19M | -253.99M | -247.58M | -241.26M | -236.16M | -230.28M | -223.45M | -217.54M | -211.21M | -203.26M | -206.04M | -201.39M | -193.75M | -221.76M | -214.06M | -207.79M | -200.79M | -192.86M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | 0.00 | n/a |
Shareholders Equity | 6.52M | -1.47M | 4.75M | 4.42M | 4.46M | 6.1M | 12.22M | 14.72M | 16.25M | 23.26M | 17.97M | 15.76M | 23.05M | -5.88M | 1.22M | 7.29M | 13.88M | 10.5M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |